# Imaging NSCLC Treatment Response to Immunotherapy

> **NCT02753569** · — · COMPLETED · sponsor: **Institute of Cancer Research, United Kingdom** · enrollment: 10 (actual)

## Conditions studied

- Cancer

## Interventions

- **OTHER:** Imaging - DW-MRI
- **RADIATION:** FDG PET-CT

## Key facts

- **NCT ID:** NCT02753569
- **Lead sponsor:** Institute of Cancer Research, United Kingdom
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2016-05-31
- **Primary completion:** 2020-05-14
- **Final completion:** 2020-05-14
- **Target enrollment:** 10 (ACTUAL)
- **Last updated:** 2021-02-01

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02753569

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02753569, "Imaging NSCLC Treatment Response to Immunotherapy". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT02753569. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*